Natixis Advisors L.P. Raises Position in Teleflex Incorporated (NYSE:TFX)

Natixis Advisors L.P. grew its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 59.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 63,092 shares of the medical technology company's stock after purchasing an additional 23,630 shares during the period. Natixis Advisors L.P. owned approximately 0.13% of Teleflex worth $15,731,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Allworth Financial LP grew its position in Teleflex by 332.3% in the third quarter. Allworth Financial LP now owns 134 shares of the medical technology company's stock worth $26,000 after buying an additional 103 shares during the last quarter. Venturi Wealth Management LLC purchased a new stake in shares of Teleflex in the 3rd quarter valued at approximately $27,000. Covestor Ltd grew its holdings in shares of Teleflex by 305.6% during the third quarter. Covestor Ltd now owns 146 shares of the medical technology company's stock valued at $29,000 after buying an additional 110 shares in the last quarter. Lindbrook Capital LLC grew its stake in Teleflex by 75.3% during the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company's stock valued at $34,000 after acquiring an additional 58 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV lifted its position in shares of Teleflex by 418.5% in the fourth quarter. Massmutual Trust Co. FSB ADV now owns 140 shares of the medical technology company's stock worth $35,000 after purchasing an additional 113 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Stock Performance

Shares of TFX traded up $0.56 during midday trading on Tuesday, reaching $201.52. 374,466 shares of the stock were exchanged, compared to its average volume of 285,820. The company has a quick ratio of 1.41, a current ratio of 2.51 and a debt-to-equity ratio of 0.37. The stock's 50 day simple moving average is $216.73 and its 200 day simple moving average is $226.68. Teleflex Incorporated has a twelve month low of $177.63 and a twelve month high of $262.97. The company has a market cap of $9.49 billion, a P/E ratio of 32.26, a PEG ratio of 1.95 and a beta of 1.13.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, May 2nd. The medical technology company reported $3.21 EPS for the quarter, topping analysts' consensus estimates of $3.07 by $0.14. Teleflex had a return on equity of 14.78% and a net margin of 9.82%. The company had revenue of $737.80 million for the quarter, compared to analysts' expectations of $726.85 million. During the same quarter last year, the business earned $3.09 earnings per share. Teleflex's revenue was up 3.8% on a year-over-year basis. On average, sell-side analysts expect that Teleflex Incorporated will post 13.72 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Wednesday, May 15th will be issued a dividend of $0.34 per share. The ex-dividend date is Tuesday, May 14th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.67%. Teleflex's dividend payout ratio (DPR) is presently 21.83%.

Insider Activity at Teleflex

In related news, VP Cameron P. Hicks sold 7,401 shares of the stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total value of $1,665,225.00. Following the transaction, the vice president now directly owns 10,050 shares in the company, valued at approximately $2,261,250. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.43% of the stock is owned by corporate insiders.

Analyst Ratings Changes

TFX has been the subject of several recent research reports. Truist Financial cut their price objective on Teleflex from $240.00 to $219.00 and set a "hold" rating for the company in a report on Friday. StockNews.com downgraded Teleflex from a "buy" rating to a "hold" rating in a report on Friday, February 23rd. Royal Bank of Canada reduced their target price on shares of Teleflex from $272.00 to $265.00 and set an "outperform" rating for the company in a research note on Friday, February 23rd. JMP Securities restated a "market outperform" rating and set a $285.00 target price on shares of Teleflex in a report on Friday, February 23rd. Finally, Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a report on Friday. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $261.75.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.